video corpo

First clinical study patient has novel drug delivery system implanted for Parkinson’s trial

Renishaw plc
Add to MyMedicalExpo favorites

Joint clinical study between Renishaw and Herantis Pharma for Parkinsons

On November 8th, 2017 the first patient in a new clinical study was implanted with a novel drug delivery system, developed by Renishaw, The procedure took place at Karolinska University Hospital in Stockholm, Sweden. The implantation marks the beginning of a joint clinical study between Renishaw and Herantis Pharma. This phase I - II clinical study will investigate the treatment of Parkinson's disease using Cerebral Dopamine Neurotrophic Factor (CDNF) delivered with Renishaw's system.

Drug delivery system - Renishaw
Drug delivery system - Renishaw

Products associated

Associated Trend items

Related Searches